Details Condition: New Format: Paperback ISBN: 9781509868087 Publisher: Picador Age Range: Adult (18+) Overview Bad Blood is John Carreyrou's Pulitzer Prize-winning investigation into Theranos, the blood-testing startup once valued at over $9 billion before collapsing into one of the biggest corporate frauds in American history. This gripping true-crime business narrative follows founder Elizabeth Holmes from Silicon Valley darling to disgraced fraudster, exposing the culture of secrecy, intimidation, and deception that hid a technology which simply didn't work — with devastating consequences for real patients. About the Book In 2014, Elizabeth Holmes was celebrated as the next Steve Jobs: a charismatic Stanford dropout whose "unicorn" startup promised to revolutionise healthcare with a single drop of blood. Backed by high-profile investors and board members, Theranos raised hundreds of millions of dollars on the promise of miniaturised blood-testing devices that could run hundreds of tests instantly and cheaply. There was just one problem — the technology never reliably worked. John Carreyrou, the Wall Street Journal reporter who first broke the story, spent years piecing together the truth from nervous whistleblowers, former employees, and confidential documents, despite legal threats and aggressive intimidation from Theranos and its lawyers. The result is a meticulously reported, page-turning account of ambition curdling into fraud: faked demonstrations, doctored data, inaccurate results sent to real patients making real medical decisions, and a corporate culture built on fear and non-disclosure agreements. Bad Blood traces the full arc of the scandal, from Theranos's dazzling rise and $9 billion valuation to Holmes's eventual criminal conviction, and remains one of the defining case studies of Silicon Valley hype outrunning scientific reality. Written by the Pulitzer Prize-winning journalist who broke the Theranos story A gripping, thriller-paced narrative built

Retailer feed snapshot imported on 21 October 2026. Not live-checked or automatically refreshed. Confirm delivery, stock and final price at the retailer.